Standout Papers

Vemurafenib: the first drug approved for BRAF-mutant cancer 2012 2026 2016 2021 579
  1. Vemurafenib: the first drug approved for BRAF-mutant cancer (2012)
    Gideon Bollag, James Tsai et al. Nature Reviews Drug Discovery

Immediate Impact

14 by Nobel laureates 31 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
2 intermediate papers

Works of Prabha N. Ibrahim being referenced

Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
2005
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
2004

Author Peers

Author Last Decade Papers Cites
Prabha N. Ibrahim 1034 446 277 17 1.4k
Anne G. Graham 791 497 159 15 1.3k
Marie Knockaert 1456 508 125 17 2.2k
Dean R. Artis 836 661 245 27 1.6k
Konrad F. Koehler 821 744 157 44 2.0k
Toshio Furuya 1410 377 152 43 2.1k
Ernst ter Haar 1310 360 161 24 1.9k
John R. Regan 981 507 83 19 1.4k
Pier F. Cirillo 1011 768 100 29 1.7k
Yoan Ferandin 945 895 177 34 2.0k
Kevin Kish 910 371 165 38 1.9k

All Works

Loading papers...

Rankless by CCL
2026